Evan G. Dick

Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA.

Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA.

Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA.

NeXeption LLC operates as a biopharmaceutical assets management firm. It provides biopharmaceutical management services, product opportunities, management expertise and funding. The firm offers an alternative pipeline development path for non-progressing assets or science and provide the appropriate resources and access to capital to advance assets from concept through commercialization. The company was founded by Stephen A. Tullman, Kamil Ali-Jackson and Neal S. Walker in 2011 and is headquartered in Malvern, PA.

Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA.

G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985.